Benefits and Risks of SGLT-2 Inhibitors in Type 2 Diabetes Care
What are SGLT-2 Inhibitors?
The sodium-glucose cotransporter-2 proteins in the kidneys are the target of a class of oral diabetic medications known as SGLT-2 inhibitors. Diabetes is associated with high blood glucose levels because of these transporters' normal ability to reabsorb glucose from the urine back into the circulation. SGLT-2 inhibitors facilitate the excretion of excess glucose...
0 Comments
0 Shares